CACNB4 Gene Episodic Ataxia Type 5 Genetic Test
Introduction
The CACNB4 gene is associated with Episodic Ataxia Type 5 (EA5), a rare genetic disorder that affects the nervous system. EA5 is characterized by recurrent episodes of ataxia, dizziness, vertigo, muscle weakness, and lack of coordination of voluntary movements.
Test Details
The CACNB4 Gene Episodic Ataxia Type 5 Genetic Test is a comprehensive analysis of an individual’s genetic makeup. It uses NGS (Next-Generation Sequencing) technology to analyze the CACNB4 gene for any mutations or variations that may be causing the disorder.
Test Components and Price
- Test Name: CACNB4 Gene Episodic Ataxia Type 5 Genetic Test
- Price: 4400.0 AED
Sample Condition
The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
The test results will be delivered within 3 to 4 weeks.
Test Type
The CACNB4 Gene Episodic Ataxia Type 5 Genetic Test falls under the category of Neurological Disorders.
Doctor and Test Department
The test is conducted by a Neurologist and is part of the Genetics department.
Pre Test Information
Prior to the test, a Genetic Counselling session is conducted to gather the clinical history of the patient and draw a pedigree chart of family members affected by CACNB4 Gene Episodic Ataxia Type 5.
Treatment and Management
Treatment for EA5 may involve medication to manage symptoms, physical therapy to improve coordination, and lifestyle changes to avoid triggers that may worsen symptoms.
Conclusion
The CACNB4 Gene Episodic Ataxia Type 5 Genetic Test is a valuable tool for diagnosing EA5 and providing information on the genetic basis of the disorder. It can also help identify carriers of the mutation and provide information for genetic counseling.
Test Name | CACNB4 Gene Episodic ataxia type 5 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CACNB4 Gene Episodic ataxia type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CACNB4 Gene Episodic ataxia type 5 |
Test Details |
The CACNB4 gene is associated with Episodic Ataxia Type 5 (EA5), which is a rare genetic disorder that affects the nervous system. EA5 is characterized by recurrent episodes of ataxia, which is a lack of coordination of voluntary movements. Other symptoms may include dizziness, vertigo, and muscle weakness. NGS (Next-Generation Sequencing) is a genetic test that can analyze multiple genes simultaneously, providing a comprehensive analysis of an individual’s genetic makeup. The NGS genetic test for EA5 involves sequencing the CACNB4 gene to identify any mutations or variations that may be causing the disorder. This test can help diagnose EA5 and provide information on the genetic basis of the disorder. It can also help identify carriers of the mutation and provide information for genetic counseling. Treatment for EA5 may involve medication to manage symptoms, physical therapy to improve coordination, and lifestyle changes to avoid triggers that may exacerbate symptoms. |